Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does OXALIPLATIN Cause Type iii immune complex mediated reaction? 23 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Type iii immune complex mediated reaction have been filed in association with OXALIPLATIN (Oxaliplatin). This represents 0.0% of all adverse event reports for OXALIPLATIN.

23
Reports of Type iii immune complex mediated reaction with OXALIPLATIN
0.0%
of all OXALIPLATIN reports
0
Deaths
12
Hospitalizations

How Dangerous Is Type iii immune complex mediated reaction From OXALIPLATIN?

Of the 23 reports, 12 (52.2%) required hospitalization, and 9 (39.1%) were considered life-threatening.

Is Type iii immune complex mediated reaction Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for OXALIPLATIN. However, 23 reports have been filed with the FAERS database.

What Other Side Effects Does OXALIPLATIN Cause?

Diarrhoea (4,963) Nausea (4,250) Neuropathy peripheral (3,662) Off label use (3,603) Neutropenia (3,391) Vomiting (3,383) Disease progression (3,370) Thrombocytopenia (2,886) Dyspnoea (2,779) Pyrexia (2,269)

What Other Drugs Cause Type iii immune complex mediated reaction?

RITUXIMAB (25) VANCOMYCIN (24) HUMAN IMMUNOGLOBULIN G (23) METHOTREXATE (19) MYCOPHENOLATE MOFETIL (18) TACROLIMUS (18) CYCLOPHOSPHAMIDE (17) BORTEZOMIB (16) CYCLOSPORINE (16) IMATINIB (16)

Which OXALIPLATIN Alternatives Have Lower Type iii immune complex mediated reaction Risk?

OXALIPLATIN vs OXAPROZIN OXALIPLATIN vs OXAZEPAM OXALIPLATIN vs OXCARBAZEPINE OXALIPLATIN vs OXITRIPTAN OXALIPLATIN vs OXOMEMAZINE

Related Pages

OXALIPLATIN Full Profile All Type iii immune complex mediated reaction Reports All Drugs Causing Type iii immune complex mediated reaction OXALIPLATIN Demographics